VytronUS: VytronUS raises $49m to support cardiac mapping & ablation system

Cardiac mapping & ablation system developer VytronUS said today it raised $49 million in a Series C round of equity financing. Funds from the round will go to support technology refinements and clinical trials for the Sunnyvale, Calif.-based company's low-intensity collimated ultrasound cardiac mapping and ablation system designed to treat atrial fibrillation and other arrhythmias. [...]The post VytronUS raises $49m to support cardiac mapping & ablation system appeared first on MassDevice.